Anti-podocalyxin antibodies and methods of using the same
US12053524B2 · kind B2 · utility
0Cited by
2References
17Claims
0Family size
Inventors
Key dates
| Filing date | Aug 13, 2021 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Nov 16, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/41
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to anti-podocalyxin antibodies, compositions comprising the same, and methods of using such antibodies and compositions for the prevention, diagnosis and treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.